Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
about
MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells.Interleukin-1β mediates virus-induced m2 muscarinic receptor dysfunction and airway hyperreactivity.Recommendation for optimal management of severe refractory asthma.Role of TNF-α in virus-induced airway hyperresponsiveness and neuronal M₂ muscarinic receptor dysfunction.Pharmacotherapy of severe asthmaTNFalpha blockade in human diseases: an overview of efficacy and safety.A functional CD86 polymorphism associated with asthma and related allergic disorders.Targeting TNF-alpha: a novel therapeutic approach for asthmaCytokine-producing effector B cells regulate type 2 immunity to H. polygyrus.Use of biologicals as immunotherapy in asthma and related diseases.Monoclonal antibodies for the treatment of severe asthma.Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma.Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.Allergen-induced CD11b+ CD11c(int) CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model.Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigsTNF-α-induces airway hyperresponsiveness to cholinergic stimulation in guinea pig airwaysHuai Qi Huang corrects the balance of Th1/Th2 and Treg/Th17 in an ovalbumin-induced asthma mouse model.Suppressive effect of low-level laser therapy on tracheal hyperresponsiveness and lung inflammation in rat subjected to intestinal ischemia and reperfusion.Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection.
P2860
Q34145885-27039E88-C8E7-4891-A7E1-7336036287B5Q34305545-2CA20B53-79B5-4CAF-8AE7-5892B3D51CA1Q34620187-6AD72DD1-0CF7-4F1B-BE75-60AF05C6C4DBQ35287436-BEDF31C6-CF91-4233-9D83-3E61145D2BFAQ35322603-6DF32E41-AE50-4176-A529-462D4575E198Q36536861-B1DD3DBF-94F8-441A-9E0E-6714995178F5Q37004558-73370F61-313F-4136-9200-8528BA7DDD4EQ37013367-A85B469B-1D6D-48E9-B51D-0171EF920BA8Q37349889-E2DFE521-79A1-4D17-9BF0-DD199658B986Q37754792-CA5E2DB3-A14C-4444-98CE-24A8E6203257Q37848219-DE7C7708-BD6F-4849-90EB-7EBAAE2ACC9BQ38071691-B635B39E-D602-46E2-B548-878BEB98300EQ38211700-1DE5ABF5-DDBD-4BF3-A92E-A9DC8ED2971BQ38503730-5D6B9DDD-BA8A-40C4-B264-610D209B2CF2Q39897143-E0F3582A-4D2D-47B7-BA9E-0306EF2D24A3Q42102471-7802850A-BE5D-4FB0-9E43-C0A3BC200128Q47106811-0F9A7B77-FC54-44F2-A49B-23DC7E60DDD8Q50247511-54BDC603-2A80-46A9-9DD6-A728BA759E78Q54378014-7E4F7B6A-583E-4123-B405-06A19B3607EE
P2860
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@ast
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@en
type
label
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@ast
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@en
prefLabel
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@ast
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@en
P921
P1476
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
@en
P2093
Mario Cazzola
Riccardo Polosa
P356
10.1097/01.ALL.0000199798.10047.74
P577
2006-02-01T00:00:00Z